vTv is excited to share our new corporate presentation which highlights the transformative potential of TTP399, along with the opportunity to monetize additional assets in our portfolio due to the great work of our global partners!
Check it out here: https://t.co/T3bjU52bXD
We are excited to welcome Deepa Prasad to vTv Therapeutics as our new President and CEO. For more than 20 years, Deepa has been deeply involved in driving progress in healthcare.
$VTVT
Talking abt ‘#Diversity in the World of #VC/PE’ at #TiEcon2021: Alicia Sontag, co-founder Prelude Growth Partners, David T. ibnAle founding partner Advance Venture Partners, Garhen Kong, Managing Partner HealthQuest Capital, Deepa Prasad, Managing Director, WestRiver Group
#DEI